Cargando…
Alu methylation serves as a biomarker for non-invasive diagnosis of glioma
Current techniques for diagnosing glioma are invasive and do not accurately predict prognosis. We developed a novel, non-invasive liquid chip assay to diagnose glioma and predict prognosis. Using this method, we determined the methylation state of the Alu element in cell-free DNA extracted from the...
Autores principales: | Chen, Jian, Huan, Wei, Zuo, Hao, Zhao, Longxiang, Huang, Chuanjun, Liu, Xiaojiang, Hou, Shiqiang, Qi, Jing, Shi, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041967/ https://www.ncbi.nlm.nih.gov/pubmed/27028997 http://dx.doi.org/10.18632/oncotarget.8318 |
Ejemplares similares
-
Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017) -
Genome-wide perturbations of Alu expression and Alu-associated post-transcriptional regulations distinguish oligodendroglioma from other gliomas
por: Hwang, Taeyoung, et al.
Publicado: (2022) -
DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker
por: Zhang, Jingwen, et al.
Publicado: (2021) -
Methylation status of individual CpG sites within Alu elements in the human genome and Alu hypomethylation in gastric carcinomas
por: Xiang, Shengyan, et al.
Publicado: (2010) -
PopAlu: population-scale detection of Alu polymorphisms
por: Qian, Yu, et al.
Publicado: (2015)